Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Northwest Biotherapeutics Company Profile (NASDAQ:NWBO)

Consensus Ratings for Northwest Biotherapeutics (NASDAQ:NWBO) (?)
Ratings Breakdown: 1 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $10.05 (52.27% upside)

Analysts' Ratings History for Northwest Biotherapeutics (NASDAQ:NWBO)
Show:
DateFirmActionRatingPrice TargetDetailsShare
3/12/2014OppenheimerDowngradeOutperform -> Market Perform$5.00ViewTweet This Rating  Share This Rating on StockTwits
3/11/2014Summer StreetBoost Price TargetBuy$10.33 -> $15.10ViewTweet This Rating  Share This Rating on StockTwits
10/16/2013OppenheimerInitiated CoverageNeutral -> Outperform$5.00ViewTweet This Rating  Share This Rating on StockTwits
9/19/2013Summer StreetInitiated CoverageBuy$10.33ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 8/1/2012 forward)